Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 4/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | MME | P08473 | 2/20 | 0.40 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL232441 | 1.00 | ALDH1A1 (0.45) | ALDH1A1CA2CA1SMN1; SMN2KDM4E | |
| SCHEMBL17439187 | 1.00 | ALDH1A1 (0.45) | ALDH1A1CA2CA1SMN1; SMN2KDM4E | |
| SCHEMBL20951937 | 1.00 | ALDH1A1 (0.45) | ALDH1A1CA2CA1SMN1; SMN2KDM4E | |
| SCHEMBL6026642 | 1.00 | ALDH1A1 (0.45) | ALDH1A1CA2CA1SMN1; SMN2KDM4E | |
| SCHEMBL359087 | 1.00 | ALDH1A1 (0.45) | ALDH1A1CA2CA1SMN1; SMN2KDM4E | |
| SCHEMBL23896338 | 1.00 | ALDH1A1 (0.45) | ALDH1A1CA2CA1SMN1; SMN2KDM4E | |
| SCHEMBL6026636 | 1.00 | ALDH1A1 (0.45) | ALDH1A1CA2CA1SMN1; SMN2KDM4E | |
| Benzene SCHEMBL3449157 | 0.95 | MME (0.45) | ALDH1A1CA2CA1SMN1; SMN2KDM4E | |
| Glycine SCHEMBL20898378 | 0.88 | ALDH1A1 (0.41) | ALDH1A1CA2CA1SMN1; SMN2KDM4E | |
| SCHEMBL30953203 | 0.88 | MME (0.41) | ALDH1A1CA2CA1SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 594 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12584101-B2 | Compositions and method of use for H5 competent Bifidobacterium longum subsp. Infantis | INFINANT HEALTH, INC. (US) | 2026-03-24 | — | — | US | claimed |
| US-20250388855-A1 | COMPOSITIONS AND METHOD OF USE FOR H5 COMPETENT BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS | Infinant Health, Inc (US) | 2025-12-25 | — | — | US | claimed |
| EP-3555615-B9 | MASS SPECTROMETRY ASSAY METHOD FOR DETECTION AND QUANTITATION OF KIDNEY FUNCTION METABOLITES | METABOLON INC (US) | 2025-03-19 | — | — | EP | claimed |
| EP-3555615-B1 | MASS SPECTROMETRY ASSAY METHOD FOR DETECTION AND QUANTITATION OF KIDNEY FUNCTION METABOLITES | METABOLON INC (US) | 2024-10-30 | — | — | EP | claimed |
| US-12076432-B2 | Method of repairing oxidatively treated hair | CONOPCO, INC. (US) | 2024-09-03 | — | — | US | claimed |
| US-20240271083-A1 | COMPOSITIONS AND METHOD OF USE FOR H5 COMPETENT BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS | INFINANT HEALTH, INC. (US) | 2024-08-15 | — | — | US | claimed |
| CN-109563127-B | Compounds, agents and uses thereof | 麦特博隆股份有限公司 | 2024-01-05 | — | — | CN | claimed |
| US-11833127-B2 | Compositions and methods for the treatment of fat infiltration in muscle | AXCELLA HEALTH INC. (US) | 2023-12-05 | — | — | US | claimed |
| CN-117147751-A | Metabolic marker combination for assessing cardiovascular disease risk in a subject and uses thereof | 深圳市绘云生物科技有限公司 | 2023-12-01 | — | — | CN | claimed |
| CN-110088615-B | Mass spectrometry assay for detection and quantification of renal function metabolites | 梅塔博隆股份有限公司 | 2023-08-22 | — | — | CN | claimed |
| US-20060063827-A1 | Systemic administration of therapeutic amino acids and N-acetylamino acids | YU RUEY J | 2006-03-23 | — | — | US | claimed |
| EP-1570840-A2 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | Yu, Ruey J., Dr. (US) | 2005-09-07 | — | — | EP | claimed |
| US-20050171194-A1 | Enlargement of mucocutaneous or cutaneous organs and sites with topical compositions | YU RUEY J (US) | 2005-08-04 | — | — | US | claimed |
| WO-2005055947-A2 | ENLARGEMENT OF MUCOCUTANEOUS OR CUTANEOUS ORGANS AND SITES WITH TOPICAL COMPOSITIONS | YU RUEY J (US) | 2005-06-23 | — | — | WO | claimed |
| US-6524593-B1 | Alleviate or improve various cosmetic conditions and dermatological disorders, skin, hair, nails | TRISTRATA, INC. | 2003-02-25 | — | — | US | claimed |
| US-6159485-A | COSMETICS; SKIN DISORDERS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-12-12 | — | — | US | claimed |
| WO-2000040217-B1 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-10-05 | — | — | WO | claimed |
| US-5519000-A | OLIGOPEPTIDE | CENTECOR, INC. (US) | 1996-05-21 | — | — | US | claimed |
| WO-1995026744-A1 | TUMOR NECROSIS FACTOR INHIBITORS | CENTOCOR, INC. (US) | 1995-10-12 | — | — | WO | claimed |
| US-5008372-A | Reacting with anhydrous trifluoroacetic acid | CORNELL RESEARCH FOUNDATION, INC. (US) | 1991-04-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12584101-B2 | Compositions and method of use for H5 competent Bifidobacterium longum subsp. Infantis | FUT5, VNN1, FUT8 | ALDH1A1 3094/4885CA2 3993/4885CA1 2740/4885 |
| US-20250388855-A1 | COMPOSITIONS AND METHOD OF USE FOR H5 COMPETENT BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS | MRPL21, VNN1, NT5M | ALDH1A1 3766/4885CA2 4792/4885CA1 4285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.